Количество 3
Количество 3
CVE-2021-2110
Vulnerability in the Oracle Argus Safety product of Oracle Health Sciences Applications (component: Letters). The supported version that is affected is 8.2.2. Easily exploitable vulnerability allows low privileged attacker with network access via HTTP to compromise Oracle Argus Safety. While the vulnerability is in Oracle Argus Safety, attacks may significantly impact additional products. Successful attacks of this vulnerability can result in unauthorized read access to a subset of Oracle Argus Safety accessible data. CVSS 3.1 Base Score 5.0 (Confidentiality impacts). CVSS Vector: (CVSS:3.1/AV:N/AC:L/PR:L/UI:N/S:C/C:L/I:N/A:N).
GHSA-9p74-pqx9-3mrw
Vulnerability in the Oracle Argus Safety product of Oracle Health Sciences Applications (component: Letters). The supported version that is affected is 8.2.2. Easily exploitable vulnerability allows low privileged attacker with network access via HTTP to compromise Oracle Argus Safety. While the vulnerability is in Oracle Argus Safety, attacks may significantly impact additional products. Successful attacks of this vulnerability can result in unauthorized read access to a subset of Oracle Argus Safety accessible data. CVSS 3.1 Base Score 5.0 (Confidentiality impacts). CVSS Vector: (CVSS:3.1/AV:N/AC:L/PR:L/UI:N/S:C/C:L/I:N/A:N).
BDU:2021-00438
Уязвимость компонента Letters платформы фармаконадзора Oracle Argus Safety, позволяющая нарушителю получить несанкционированный доступ к защищаемой информации
Уязвимостей на страницу
Уязвимость | CVSS | EPSS | Опубликовано | |
|---|---|---|---|---|
CVE-2021-2110 Vulnerability in the Oracle Argus Safety product of Oracle Health Sciences Applications (component: Letters). The supported version that is affected is 8.2.2. Easily exploitable vulnerability allows low privileged attacker with network access via HTTP to compromise Oracle Argus Safety. While the vulnerability is in Oracle Argus Safety, attacks may significantly impact additional products. Successful attacks of this vulnerability can result in unauthorized read access to a subset of Oracle Argus Safety accessible data. CVSS 3.1 Base Score 5.0 (Confidentiality impacts). CVSS Vector: (CVSS:3.1/AV:N/AC:L/PR:L/UI:N/S:C/C:L/I:N/A:N). | CVSS3: 5 | 0% Низкий | около 5 лет назад | |
GHSA-9p74-pqx9-3mrw Vulnerability in the Oracle Argus Safety product of Oracle Health Sciences Applications (component: Letters). The supported version that is affected is 8.2.2. Easily exploitable vulnerability allows low privileged attacker with network access via HTTP to compromise Oracle Argus Safety. While the vulnerability is in Oracle Argus Safety, attacks may significantly impact additional products. Successful attacks of this vulnerability can result in unauthorized read access to a subset of Oracle Argus Safety accessible data. CVSS 3.1 Base Score 5.0 (Confidentiality impacts). CVSS Vector: (CVSS:3.1/AV:N/AC:L/PR:L/UI:N/S:C/C:L/I:N/A:N). | 0% Низкий | больше 3 лет назад | ||
BDU:2021-00438 Уязвимость компонента Letters платформы фармаконадзора Oracle Argus Safety, позволяющая нарушителю получить несанкционированный доступ к защищаемой информации | CVSS3: 5 | 0% Низкий | около 5 лет назад |
Уязвимостей на страницу